Current AusVaxSafety surveillance data
Last updated 16 March 2018
ZOSTER (SHINGLES) VACCINE SAFETY DATA
There is currently a low rate of events and medical attendance following zoster vaccine, which is consistent with the existing knowledge of the vaccine safety profile.
It is important to re-emphasise that zoster vaccine should not be given to immunocompromised individuals. For more information please refer to the Therapeutic Goods Administration (TGA) website.
PERTUSSIS (WHOOPING COUGH) VACCINE SAFETY DATA
Injection site reactions are known to occur following administration of acellular pertussis vaccines. The current reported event rates are consistent with existing data on pertussis vaccines.
INFLUENZA VACCINE SAFETY DATA
In 2017, four age-specific quadrivalent influenza vaccines were available under the National Immunisation Program (NIP). The safety profile of the 2017 vaccines was reassuring and consistent with expectations. Surveillance will recommence at the beginning of the influenza season, in April 2018.